CY1112389T1 - DRY POWDER COMPOSITION INCLUDING EFFECTIVENESS OF CO-EXPLOSION FOR PULMONARY INHALATION - Google Patents

DRY POWDER COMPOSITION INCLUDING EFFECTIVENESS OF CO-EXPLOSION FOR PULMONARY INHALATION

Info

Publication number
CY1112389T1
CY1112389T1 CY20121100187T CY121100187T CY1112389T1 CY 1112389 T1 CY1112389 T1 CY 1112389T1 CY 20121100187 T CY20121100187 T CY 20121100187T CY 121100187 T CY121100187 T CY 121100187T CY 1112389 T1 CY1112389 T1 CY 1112389T1
Authority
CY
Cyprus
Prior art keywords
dry powder
explosion
composition including
powder composition
pulmonary inhalation
Prior art date
Application number
CY20121100187T
Other languages
Greek (el)
Inventor
David Morton
John Staniforth
Original Assignee
Vectura Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0321607.4A external-priority patent/GB0321607D0/en
Application filed by Vectura Limited filed Critical Vectura Limited
Publication of CY1112389T1 publication Critical patent/CY1112389T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
    • B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
    • B02C19/00—Other disintegrating devices or methods
    • B02C19/06—Jet mills

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με φαρμακευτικές συνθέσεις ξηράς κόνεως που περιλαμβάνει βενζοδιαζεπίνη για χορήγηση μέσω εισπνοής, και ειδικότερα, συνθέσεις ξηράς κόνεως βενζοδιαζεπίνης και ιατροτεχνολογικές συσκευές εισπνευστήρων για χορήγηση των ιδίων.The present invention relates to dry powder pharmaceutical compositions comprising benzodiazepine for inhalation administration, and in particular, benzodiazepine dry powder compositions and medical inhaler devices for administration thereof.

CY20121100187T 2003-09-15 2012-02-23 DRY POWDER COMPOSITION INCLUDING EFFECTIVENESS OF CO-EXPLOSION FOR PULMONARY INHALATION CY1112389T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0321607.4A GB0321607D0 (en) 2003-09-15 2003-09-15 Manufacture of pharmaceutical compositions
EP04768542A EP1663155B1 (en) 2003-09-15 2004-09-15 Dry powder composition comprising co-jet milled particles for pulmonary inhalation

Publications (1)

Publication Number Publication Date
CY1112389T1 true CY1112389T1 (en) 2015-12-09

Family

ID=45217849

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20121100187T CY1112389T1 (en) 2003-09-15 2012-02-23 DRY POWDER COMPOSITION INCLUDING EFFECTIVENESS OF CO-EXPLOSION FOR PULMONARY INHALATION

Country Status (5)

Country Link
AT (1) ATE535233T1 (en)
CY (1) CY1112389T1 (en)
ES (2) ES2377205T3 (en)
HK (1) HK1092068A1 (en)
SI (1) SI1663155T1 (en)

Also Published As

Publication number Publication date
ES2377205T3 (en) 2012-03-23
ATE535233T1 (en) 2011-12-15
HK1092068A1 (en) 2007-02-02
ES2671546T3 (en) 2018-06-07
SI1663155T1 (en) 2012-07-31

Similar Documents

Publication Publication Date Title
NO20062504L (en) Compositions and dosage forms for improved absorption
CY1115414T1 (en) Substituted 1-3-bisphenylpropane derivatives, preparations and their uses
ITMI20051999A1 (en) INHALATION FORMULATIONS OF DRUGS IN DRY POWDER FOR ADMINISTRATION AS SUCH OR WITH NEBULIZER AND EQUIPPED WITH HIGH EROGABILITY RESPIRABILITY AND STABILITY
ATE381323T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING FLAVONOIDS AND MENTHOL
WO2005115406A3 (en) 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
ATE452129T1 (en) N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES
HUP0101293A2 (en) Aspb28-human insulin comprising pharmaceutical composition administered by inhalation and their use
CY1111726T1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ASTHMA
CY1115056T1 (en) Pharmaceutical Compositions Containing Fentanyl For Intranasal Administration
CY1111541T1 (en) B-2 TREATMENT AGENTS FOR THE TREATMENT OF SKIN CONDUCTIVE MATTER DISEASES
CY1112682T1 (en) Active IL-18 Protein Conjugates and their Medical Uses
ES2187300A1 (en) Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
CY1106430T1 (en) MEDICATIONS FOR INHALATION CONTAINING VITAMINS AND AN ANTICHOLINEPG
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
CY1113116T1 (en) Substituted 4-Aminocyclohexanols
CY1109361T1 (en) Substituted 4-Aminocyclohexanols
TR201910393T4 (en) Mouthpiece for an inhaler.
WO2008087365A3 (en) Substituted 1, 3-diphenylpropane derivatives, preparations and uses of same
EA201000677A1 (en) DRY POWDERED COMPOSITIONS CONTAINING DERIVATIVES OF ASCORBIC ACID
CY1109537T1 (en) Peptides and Peptide Derivatives, PREPARATION OF THESE ALSO USE THESE FOR THE PREPARATION OF THERAPEUTIC AND / OR PREVENTIVE ACTIVE ACTION
CY1107231T1 (en) Substituted 4-Aminocyclohexanol derivatives
CY1110369T1 (en) NEW COOPERATIVE COMBINATION THAT INCLUDES Roflumilast And Formoterol
ECSP088287A (en) A COMBINATION OF COMPOUNDS THAT CAN BE USED IN THE TREATMENT OF RESPIRATORY DISEASES, ESPECIALLY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND ASTHMA
CY1115266T1 (en) PHARMACEUTICAL COMPOSITIONS OF FORMOTEROL AND DIPROPIONATE VECLOMETHASONE